Efaroxan (Compound)

Synonyms:Efaroxan, 89197-32-0, Efaroxan (hydrochloride), DTXSID8045149, 2-(2-ethyl-3H-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole, G00490L21H, NSC-759562, NCGC00015410-04, RX 821037, DTXCID6025149, Efaroxanum, Efaroxano, Efaroxanum [INN-Latin], 2-(2-Ethyl-2,3-dihydrobenzofuran-2-yl)-4,5-dihydro-1H-imidazole, Efaroxano [INN-Spanish], CAS-89197-32-0, Efaroxan [INN:BAN], UNII-G00490L21H, Spectrum_001997, EFAROXAN [INN], Spectrum3_001863, Lopac0_000521, BSPBio_003306, KBioSS_002570, CHEMBL57895, SCHEMBL127096, CHEBI:93806, KBio2_002561, KBio2_005129, KBio2_007697, KBio3_002808, (+-)-2-(2-Ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline, HMS2089D15, Tox21 110139, Tox21_110139, 1H-Imidazole, 2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-4,5-dihydro-, BDBM50179393, Tox21_110139_1, CCG-204611, NSC 759562, SDCCGSBI-0050504.P003, MRF-0000021, NCGC00015410-03, NCGC00015410-05, NCGC00015410-06, NCGC00015410-08, NCGC00015410-13, NCGC00024793-02, NCGC00024793-03, SBI-0050504.P002, FT-0725797, AB00918533_03, L001351, Q5347187, BRD-A10739734-003-05-6, (+/-)-2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline, 2-(2-ethyl-2,3-dihydro-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole, 2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-4,5-DIHYDRO-1H-IMIDAZOLE

Pubchem:PUBCHEM:72016

Id:fc0f0e33-ad9f-50c1-9d31-d2db8f627e58

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Efaroxan's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Efaroxan.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Efaroxan.

Results found

Linked to

	Label	Description
	BRD-A10739734-003-05-6 Substance (Entity type)	A Substance
	Efaroxan negatively regulates IGFBP2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Efaroxan positively regulates FZD6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Efaroxan positively regulates POLG2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Efaroxan in similarity relationship with 3-Bicyclo[2.2.1]hept-5-en-2-yl-7-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda6-benzo[1,2,4]thiadiazine-6-sulfonic acid amide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Efaroxan negatively regulates SDC4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Efaroxan negatively regulates IFITM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Efaroxan negatively regulates SNCA Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Efaroxan positively regulates ASF1A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Efaroxan negatively regulates SLC7A1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-A10739734-003-05-6

Substance (Entity type)

A Substance

Efaroxan negatively regulates IGFBP2

Knowledge Graph Assertion (Entity type)